GR

George Rathmann

North America, Wisconsin, United States, Milwaukee

Description

George Rathmann is the CEO at Amgen Foundation.

Investor Profile

George Rathmann has made 2 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Series C (50%)
  • Series B (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Analytics
  • Genetics
  • Health Care
  • Clinical Trials
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does George Rathmann frequently co-invest with?

Band of Angels
North America, California, United States, Menlo Park
Co-Investments: 1
Allen & Company
North America, Florida, United States, Lakeland
Co-Investments: 1
M
North America, New York, United States, New York
Co-Investments: 1
CX Venture Group
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 1
Sutter Hill Ventures
North America, California, United States, Palo Alto
Co-Investments: 1
NB
North America, Maryland, United States, Gaithersburg
Co-Investments: 1
Radius Ventures
North America, New York, United States, New York
Co-Investments: 1
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1

Which angels does George Rathmann often collaborate with?

JN
North America, California, United States, San Carlos
Shared Deals: 1
WR
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by George Rathmann?

Cellerant Therapeutics

San Carlos, California, United States

Cellerant Therapeutics is a clinical-stage company developing innovative cell- and antibody-based immunotherapies.

BiotechnologyClinical TrialsTherapeutics
Series BMay 11, 2005
Amount Raised: $16,000,000
NuGEN Technologies

San Carlos, California, United States

NuGEN Technology is a provider of genomics sample preparation solutions enabling scientists to access true biology in all samples.

AnalyticsBiotechnologyGeneticsHealth Care
Series CAug 20, 2003
Amount Raised: $7,500,000